CTR20260391 clinical trial report covering SYHX-1901, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07388524 clinical trial report covering Atezolizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07393321 clinical trial report covering Fulvestrant, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07391657 clinical trial report covering GC-012F, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07393542 clinical trial report covering Adebrelimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20260187 clinical trial report covering Hydroxocobalamin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07394114 clinical trial report covering Poterepatide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07392060 clinical trial report covering WXFL10030390, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07391774 clinical trial report covering Letrozole, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07393802 clinical trial report covering Resveratrol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07393282 clinical trial report covering Linvoseltamab-gcpt, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07393659 clinical trial report covering Dolutegravir Sodium/Lamivudine, Phase 3, endpoints, sponsor, geography, readout timing and development white spa